Xu Zhenyu 4

What Happened Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), reported a sale of 4,000 common shares on May 13, 2026. The filing shows a weighted average sale price of $4.54 per share for a total proceeds of approximately $18,168. The sale is reported under transaction code "S" (sale) and was made pursuant to a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: May 13, 2026; filing date (Form 4): May 14, 2026.
• Price: weighted average $4.54 per share; individual trade prices ranged from $4.48 to $4.65 (footnote provides per-price breakdown on request).
• Shares sold: 4,000; proceeds ≈ $18,168.
• Method/code: Reported as sale (S), pursuant to a 10b5-1(c) trading plan (footnote F1).
• Shares owned after transaction: Not specified in the excerpt provided.
• Timeliness: Filed the day after the transaction; no late filing indicated in the provided information.

Context This was a sale executed under a pre-arranged 10b5-1 plan, which is commonly used by insiders to sell shares according to a preset schedule and is generally viewed as routine rather than a direct signal of changed sentiment. For retail investors, purchases tend to carry more informational weight than routine sales; this report documents a modest-sized disposition by an executive.